ACRVBiotechnology / Biotechnology
Acrivon Therapeutics Inc
30-Day Price
Key Metrics
Latest Close
$1.66
Market Cap
$52M
Shares Outstanding
31,560,000
P/B Ratio
1.06
ROE
-4557.00%
ROA
-4098.00%
Debt / Equity
0
Current Ratio
10.55
Want the full picture?
Sign up free for full analysis, strategy backtesting with credibility scoring, portfolio management, and more.
Start Free